D-1597-2020 Class II Terminated

Recalled by RLC Labs Inc. — Phoenix, AZ

Recall Details

Product Type
Drugs
Report Date
September 23, 2020
Initiation Date
August 25, 2020
Termination Date
November 8, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
N/A

Product Description

Nature-Throid, Thyroid USP [liothyronine (T3) 6.75 mcg and levothyroxine (T4) 28.5 mcg], 3/4 Grain (48.75 mg) Tablets, packaged in a) 30-count bottles, NDC 64727-3302-4; b) 60-count bottles, NDC 64727-3302-5; c) 90-count bottles, NDC 64727-3302-6; d) 100-count bottles, NDC 64727-3302-1; and e) 1,000-count bottles, NDC 64727-3302-2; Rx Only, Manufactured by: RLC Labs Phoenix, AZ 85034.

Reason for Recall

CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

Distribution Pattern

Nationwide in the United States

Code Information

All lots with expiry between 10/2020-07/2023